+44 (0) 1223 755950
+1 832 327 7413
Efungumab
REQUEST MORE INFO
Catalogue No: abx831086
Price:
US$464.00
(Size: 100 µg)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
Efungumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Candida albicans HSP91 homolog, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Research Articles on Candida albicans HSP91 homolog
| Target | Candida albicans HSP91 homolog |
| Clonality | Monoclonal |
| Reactivity | Human |
| Expression | Recombinant |
| Tested Applications | ELISA, WB |
| Host | Human |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Liquid |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Tag | scFv-heavy Kappa |
| Buffer | 0.01 M PBS. pH 7.4. |
| CAS Number | 762260-74-2 |
| Concentration | Batch-dependent, typically between 0.5-2.0 mg/ml. |
| Availability | Shipped within 7-12 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |